Worldwide: Patent

Generative AI is rapidly transforming patent litigation workflows, from legal research and claim charts to deposition preparation and prior-art searching. As courts, bar associations, and the USPTO grapple with disclosure requirements, patent litigators face a critical challenge: understanding when and how to explain AI's role in their work while maintaining professional duties of competence, confidentiality, and verification.

As wildfire seasons intensify and spread across greater distances, innovative drone technologies are emerging as crucial tools in early detection and fire suppression. Patent filings reveal how unmanned aerial vehicles equipped with specialized cameras and ignition systems are revolutionizing wildfire management, offering safer and more efficient alternatives to traditional firefighting methods.

The Court of Federal Claims recently denied the United States’ motion to dismiss a patent infringement suit related to production of a COVID-19 vaccine. The court held that it had jurisdiction because the plaintiff filed...

Dans une décision importante pour le secteur canadien des sciences de la vie, la Cour suprême du Canada a confirmé, le 17 juillet 2026, que les schémas posologiques pharmaceutiques innovants peuvent constituer un objet brevetable.

Healthcare M&A in Canada is experiencing a significant transformation, with total deal values surging from $4.5 billion to over $12 billion as pharmaceutical companies navigate patent cliffs and pursue revenue-generating assets. As artificial intelligence reshapes transaction assessments and intellectual property diligence becomes increasingly complex, dealmakers must adopt multidisciplinary approaches that integrate regulatory, data governance, and technology considerations into their strategic evaluations

Patent trials are rarely just about the hard science of an underlying claim. They are human dramas with two competing storylines, where the Court must decide not only what the science shows, but whether the people explaining that science can be trusted.

Earlier this year, the UK Supreme Court gave its judgment in Emotional Perception AI Limited v Comptroller General of Patents, Designs and Trade Marks.

A small drafting mistake can have major consequences in patent law. That was the lesson from Enanta Pharmaceuticals, Inc. v. Pfizer Inc., where the Federal Circuit held in a precedential opinion that Enanta’s patent...

L'équipe responsable des mises à jour PI Rx examine les développements majeurs en propriété intellectuelle et en droit réglementaire des sciences de la vie au Canada durant le premier semestre 2026, incluant les nouvelles lignes directrices de la Cour fédérale, les initiatives de Santé Canada et les mises à jour du CEPMB et de l'AMC.